Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ

$--

(--)

Regular Market

Crinetics Pharmaceuticals, Inc. (CRNX) Live Price Chart

Last updated: ⁦2026-10-13 14:20:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Crinetics Pharmaceuticals, Inc. (CRNX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Price Today

Crinetics Pharmaceuticals, Inc. (CRNX) is currently trading at $-- as of --, -- from the previous close of $--

During today's regular trading session, CRNX has traded between $-- and $--, with a trading volume of -- shares. The current price is -- of today's range.

Crinetics Pharmaceuticals, Inc. (CRNX) 7-Day Stock Price Change

Over the past seven days, Crinetics Pharmaceuticals, Inc. (CRNX) moved from $84.70 to $84.95, representing a gain of 0.30% ($0.25).

The stock traded between $84.69 and $85.01 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.

The average daily volume was 2.15 million shares, down versus the previous seven-day period, indicating lower trading activity.

What is Crinetics Pharmaceuticals, Inc. (CRNX)?

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Crinetics Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	594
Exchange	NASDAQ
Company Website	https://www.crinetics.com

How to Buy Crinetics Pharmaceuticals, Inc. (CRNX) Stock on MEXC

Eligible investors can buy real shares of Crinetics Pharmaceuticals, Inc. (CRNX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CRNX and Place Your Order

Open the RealStocks trading page and search for CRNX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Crinetics Pharmaceuticals, Inc. (CRNX) stock price today?

Crinetics Pharmaceuticals, Inc. (CRNX) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is CRNX stock going up or down today?

As of --, CRNX is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is CRNX pre-market price?

As of --, CRNX is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CRNX after-hours price?

As of --, CRNX is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CRNX stock trading now?

CRNX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CRNX sit relative to its 52-week high and low?

Over the past 52 weeks, CRNX has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Crinetics Pharmaceuticals, Inc. in?

Crinetics Pharmaceuticals, Inc. (CRNX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Crinetics Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Crinetics Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CRNX valued in terms of P/E ratio and EPS?

CRNX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Crinetics Pharmaceuticals, Inc. pay a dividend?

Crinetics Pharmaceuticals, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.